Exploring the treatment burden of disease-modifying anti-rheumatic drug monitoring in people with rheumatoid arthritis.

ABSTRACT:

Objectives

People with RA taking DMARDs require safety monitoring to identify potential side effects. The aim of this study was to explore the perspectives of patients and family members on DMARD monitoring and how the associated treatment burden could be minimized to optimize concordance and safety.

Methods

Thirteen adults with RA on DMARDs and three family members participated in semi-structured telephone interviews between July 2021 and January 2022. Data were analysed using a framework method. Findings were discussed with a group of stakeholders to develop implications for practice.

Results

Two main themes were identified: (i) making sense of drug monitoring; and (ii) work involved in drug monitoring. Participants perceived DMARDs as necessary to reduce symptoms,

SUBMITTER: Ryan S 

PROVIDER: S-EPMC10307943 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature